Alcami Executive and Leadership Team

Roz Stone, the Earthware Enterprise Chief Executive Officer at Alcami, directs the overarching strategic vision and operational framework for the organization. Stone's leadership guides Alcami's mission to support pharmaceutical and biotech companies across all development phases, from early-stage analytical development through to commercial manufacturing. This executive role involves ensuring the integration of Alcami's extensive facilities, totaling 675,000 ft across the United States, to deliver innovative and customizable solutions. The focus remains on driving growth and operational excellence within the contract development and manufacturing sector. Stone's strategic direction ensures Alcami maintains its position as a key partner in advancing product lifecycles. The Earthware Enterprise Chief Executive Officer's responsibilities encompass fostering a culture of scientific rigor and client-centric service delivery, directly impacting the successful progression of client products through regulatory and manufacturing milestones. Roz Stone's executive oversight is critical for maintaining Alcami's competitive edge and expanding its service offerings in a dynamic market.

Guy Kubi, the Chief Operating Officer at Alcami, oversees the day-to-day operational execution and efficiency across the company's extensive network of facilities. Kubi's role is central to managing the 675,000 ft of operational space within the United States, ensuring seamless integration of services such as analytical development, clinical to commercial sterile and oral solid manufacturing, and packaging. This executive function involves optimizing resource allocation and streamlining processes to meet the rigorous demands of pharmaceutical and biotech clients. The Chief Operating Officer drives initiatives aimed at enhancing productivity and maintaining the highest standards of quality and compliance. Guy Kubi's leadership ensures that Alcami's manufacturing capabilities, including sterile and oral solid dosage forms, operate at peak performance. This position is critical for translating strategic objectives into tangible operational outcomes, supporting the company's mission to advance products through every stage of the development lifecycle. Kubi's operational management directly contributes to Alcami's reputation for reliability and innovation in the CDMO space.

Katie Schlipp, the President of Laboratory Operations at Alcami, leads the strategic direction and operational management of all analytical and microbiology laboratory services. Schlipp's executive responsibility involves ensuring the highest standards of scientific integrity and regulatory compliance across Alcami's extensive laboratory functions, supporting clients from early development through commercialization. This leadership position is critical for overseeing the provision of customizable solutions in analytical development, environmental monitoring, and pharmaceutical support services. Katie Schlipp drives innovation within laboratory processes, enhancing Alcami's capacity to deliver precise and reliable data essential for product advancement. The President of Laboratory Operations ensures that the 675,000 ft of facilities are equipped and staffed to meet the evolving needs of the pharmaceutical and biotech industries. Schlipp's focus on operational excellence and scientific expertise directly contributes to Alcami's reputation as a trusted contract development and manufacturing organization. This role is instrumental in maintaining Alcami's commitment to quality and client success.

Tori Arens, the President of Drug Product at Alcami, directs the strategic vision and operational execution for all drug product manufacturing activities. Arens' executive leadership is focused on advancing client products through clinical to commercial stages, encompassing both sterile and oral solid dosage forms. This role is pivotal in ensuring Alcami's manufacturing capabilities meet stringent quality and regulatory requirements, supporting pharmaceutical and biotech companies globally. The President of Drug Product oversees the integration of innovative manufacturing technologies and processes within Alcami's 675,000 ft of operational space across the United States. Tori Arens drives initiatives to enhance efficiency, scalability, and reliability in drug product development and manufacturing. This executive position is crucial for maintaining Alcami's commitment to delivering high-quality, customizable solutions that accelerate product lifecycles. Arens' leadership ensures that Alcami remains a premier partner for clients seeking expert drug product manufacturing services, contributing significantly to the company's overall mission.

Rose-Marie Nelson, the Chief Human Resources Officer at Alcami, directs all human capital strategies and organizational development initiatives. Nelson's executive purview encompasses fostering a robust company culture that supports Alcami's mission of advancing pharmaceutical and biotech products through their lifecycle. This role is vital for attracting, retaining, and developing the skilled workforce necessary to operate Alcami's 675,000 ft of facilities across the United States. The Chief Human Resources Officer ensures that HR policies and practices align with the company's commitment to innovation, quality, and client service in areas like analytical development and manufacturing. Rose-Marie Nelson's leadership focuses on building a high-performing team capable of meeting the complex demands of the contract development and manufacturing sector. This includes managing talent acquisition, employee engagement, and professional development programs that are essential for Alcami's continued growth and success. Nelson's strategic approach to human resources underpins the operational excellence required for delivering comprehensive solutions to clients.